Latest news
5 June 2020
Touchlights’s chairman to help lead UK COVID-19 vaccine effort
Dr. Clive Dix appointed as Deputy Head of the UK’s Vaccine Taskforce Hampton, UK – 5 June 2020 – Touchlight, a biotechnology company focused on the discovery and development of DNA-based genetic medicines, today commented on the news that its Chairman, Dr. Clive Dix, has been appointed Deputy Chair of the UK’s Vaccine Taskforce. In this … Continued
27 April 2020
Touchlight appoints Dr. Helen Horton as Chief Research Officer
Former J&J Senior Scientific Director and immunology expert joins at a pivotal time Touchlight driving its dbDNA technology towards clinical development in therapeutic and prophylactic vaccines Hampton, UK – 27 April 2020 – Touchlight, a biotechnology company focused on the discovery and development of DNA-based genetic medicines, today announces the appointment of Dr. Helen Horton as … Continued
Upcoming events

World Vaccine Congress
Join us at World Vaccine Congress, Washington DC (Apr 3-6, 2023).
Dr Lisa Caproni, Head of Vaccine Discovery, will be presenting on the topic “A rapid response platform for nucleic acid vaccines”.
Meet up with us and learn how our doggybone DNA can be used to enable faster, safer and more scalable DNA production than other traditional methods without contamination of the plasmid DNA backbone.